Complementary peptide therapies at Robertson Wellness & Aesthetics NAD+ is itself classified as a peptide-adjacent coenzyme, and it pairs naturally with many of the peptide therapies available at RWACenter
However, most people who consume cannabis use it in forms that affect the whole body, which are responsible for many of its reported risks
Because it does not suppress appetite, it can theoretically be combined with GLP-1 agonists to add a lipolytic component to the appetite suppression mechanism, though clinical data on this combination is lacking
At this time we have not seen any advantages of one medicine over the other, but we are still evaluating
Need custom math
The only valid comparison is clinical outcome (weight loss, appetite suppression, blood sugar control), not milligram dose